Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
31m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
31m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
31m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
31m agoFirst Quantum Minerals Reports First Quarter 2026 Results
31m agoDistrict Metals Announces $10 Million Private Placement Financing
Relay Therapeutics Inc logo

Relay Therapeutics Inc

About

Relay Therapeutics Inc (NASDAQ:RLAY) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
Apr 2 2026
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Mar 16 2026
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
Feb 26 2026
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Feb 23 2026
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

Financials

Revenue
$15.36 M
Market Cap
$2.23 B
EPS
-1.61

Community Chat

Ask AI

6ix6ixAIEvents